Etanercept [etanercept]
- Terms
-
Enbrel
-
Enbrel
Erelzi
Etanercept-szzs
Recombinant Human Dimeric TNF Receptor Type II-IgG Fusion Protein
TNF Receptor Type II-IgG Fusion Protein
TNFR-Fc Fusion Protein
TNR 001
TNR-001
TNT Receptor Fusion Protein
TNTR-Fc
A recombinant version of soluble human TNF receptor fused to an IgG FC fragment that binds specifically to TUMOR NECROSIS FACTOR and inhibits its binding with endogenous TNF receptors. It prevents the inflammatory effect of TNF and is used to treat RHEUMATOID ARTHRITIS; PSORIATIC ARTHRITIS and ANKYLOSING SPONDYLITIS.
- DUI
- D000068800 MeSH Browser
- CUI
- M0276736
- History note
- 2016 (1997)
- Public note
- 2016; ETANERCEPT was indexed under IMMUNOGLOBULIN G and RECEPTORS, TUMOR NECROSIS FACTOR 1997-2015
Allowable subheadings
- AD
- administration & dosage 35
- AE
- adverse effects 25
- AA
- analogs & derivatives 3
- BL
- blood
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification 1
- EC
- economics 3
- HI
- history
- IM
- immunology 2
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics 4
- PD
- pharmacology 11
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 71
- TO
- toxicity
- UR
- urine
GP2015 Chemical MeSH Browser
etanercept biosimilar SB4 Chemical MeSH Browser